Tag Archives: Behind

Nobel laureate behind Bristol-Myers’ I-O superstar Opdivo demands a bigger cut

Opdivo, the blockbuster cancer drug Bristol-Myers Squibb co-developed with Japan’s Ono Pharmaceutical, is a cash cow in the global market. But a Nobel laureate who helped create the drug isn’t happy with his cut. Tasuku Honjo, a Japanese immunologist and Nobel Prize winner for his identification of the immune cell protein PD-1, wants to renegotiate… Read More »

As deadline closes in, Obamacare enrollment continues to slip behind

Nearly 3.2 million people had selected plans on Obamacare’s marketplaces as of Dec. 1, the Centers for Medicare and Medicaid Services announced Thursday. The latest figures represent a roughly 10 percent drop from the year before, when more than 3.6 million people had signed up at about the same time. Enrollment has been down compared… Read More »